Immunopharmacology & Hematologic Pharmacology | Pain Management: Acute Clinical | Health Service Delivery & Management | Pain Management: Chronic Clinical
Bi-profenid (ketoprofen) in daily practice management of acute episodes of pain in acute and chronic conditions
*Corresponding author: Alain Serrie
Pain Federation, Palliative Medicine, Lariboisiere Hospital, Paris, France
F1000Posters 2010, 1: 556 (poster) [ENGLISH]
Poster [430.29 KB]
World Congress on Pain 2010, 29 Aug - 2 Sep 2010, PH 335
International Association for the Study of Pain
The primary objective of this study was to assess the impact of ketoprofen (Bi-Profenid®) in the daily practice management of acute pain.
Secondary objectives were then to list the types of treatment prescribed to treat the different types of acute pain; to compare treatment types prescribed by investigators that were users or not of Guidelines/Recommendations; to assess investigators’ knowledge on and interest for acute pain management Guidelines/Recommendations and how such Guidelines/Recommendations are used in daily practice; to determine the typology of patients receiving Bi-Profenid®) for acute pain and to confirm its good efficacy and safety in the treatment of acute pain.
This study showed that most of physicians apply the available guidelines, however the impact of these guidelines on the treatment was not optimal and no significant differences were observed between groups of patients treated following guidelines or not. Results confirmed the good efficacy of Bi-Profenid®) as an anti-inflammatory and analgesic agent in the management of acute pain in anti-inflammatory, musculoskeletal and traumatological conditions, combined with a good level of safety.
Scientific Consultant for Sanofi-aventis.
Please note that most posters on this site present work that is preliminary in nature and has not been peer reviewed.
This poster is open access subject to the CC BY-NC Creative Commons 3.0 License